BiVACOR® Receives $13 Million to Support Clinical Trial

GOLD COAST, Australia & HUNTINGTON BEACH, Calif., February 20, 2024--BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements.

Related Keywords

Sydney , New South Wales , Australia , Texas , United States , Monash , South Australia , Australian , Williame Cohn , David Kaye , Daniel Timms , Texas Heart Institute , Artificial Heart Frontiers Program , Technology Officer , Monash Alfred Baker Centre For Cardiovascular Research , University Of New South Wales , Australian Government Medical Research Future Fund , Griffith University , Monash University , University Of Queensland , Grant From Monash University , Australian Government , Medical Research Future Fund , Artificial Heart , Early Feasibility Study , Texas Heart , Chief Technology , Professor David Kaye , Monash Alfred Baker Centre , Total Artificial Heart , Heart Failure , Utah , Underserved Patients , Investigational Device Exemption , Business Wire ,